Related Experiment Video
Updated: Dec 21, 2025

A High Throughput, Multiplexed and Targeted Proteomic CSF Assay to Quantify Neurodegenerative Biomarkers and Apolipoprotein E Isoforms Status
Published on: October 20, 2016
The Important Interface Between Apolipoprotein E and Neuroinflammation in Alzheimer's Disease
Courtney M Kloske1, Donna M Wilcock1
1Department of Physiology, Sanders-Brown Center on Aging, University of Kentucky, Lexington, KY, United States.
Alzheimer's disease (AD) involves beta-amyloid plaques and tau tangles, often with neuroinflammation. This review focuses on how the ApoE4 gene variant specifically drives AD progression through neuroinflammation pathways.
Area of Science:
- Neuroscience
- Genetics
- Pathology
Background:
- Alzheimer's disease (AD) is a leading neurodegenerative disorder characterized by amyloid-beta (Aβ) plaques and tau tangles.
- Neuroinflammation is a common feature in AD, prompting research into its role in disease progression.
- Apolipoprotein E (ApoE) is a major genetic risk factor for AD, with the ApoE4 isoform significantly increasing risk.
Purpose of the Study:
- To review current literature on the mechanisms by which ApoE4 influences Alzheimer's disease progression.
- To elucidate the specific role of ApoE4 in neuroinflammation and its impact on AD pathology.
Main Methods:
- Literature review of studies investigating ApoE4, Aβ deposition, tau pathology, and neuroinflammation in Alzheimer's disease.
- Analysis of genetic risk factors and their association with AD pathogenesis.
- Synthesis of current understanding of ApoE4's molecular pathways in AD.
Main Results:
- ApoE4 is strongly associated with increased risk and severity of Alzheimer's disease.
- ApoE4 influences Aβ deposition, tau tangle formation, and exacerbates neuroinflammation.
- The precise mechanisms linking ApoE4 to these pathological processes require further elucidation.
Conclusions:
- ApoE4 plays a critical role in Alzheimer's disease pathogenesis, particularly through its modulation of neuroinflammation.
- Understanding ApoE4's mechanisms is crucial for developing targeted AD therapies.
- Further research is needed to fully unravel the complex pathways involved.
More Related Videos
09:33Quantitative 3D In Silico Modeling q3DISM of Cerebral Amyloid-beta Phagocytosis in Rodent Models of Alzheimer's Disease
Published on: December 26, 2016
06:43A Novel In Vitro Live-imaging Assay of Astrocyte-mediated Phagocytosis Using pH Indicator-conjugated Synaptosomes
Published on: February 5, 2018
Related Concept Videos
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
Alzheimer's Disease: Treatment